Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Alicante – page 13

313 clinical trials in Alicante, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Alicante at a glance
313
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

313 trials in Alicante

Open in trial search

Dermatitis atopic

Not recruiting

Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apg777
  • Sponsor:Apogee Therapeutics Inc.

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Lu Ag09222
  • Sponsor:H. Lundbeck A/S

Hidradenitis

Not recruiting

Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Neurodermatitis

Not recruiting

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Dermatitis atopic

Not recruiting

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Hidradenitis

Not recruiting

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Dermatitis atopic

Not recruiting

Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18
  • Sponsor:Glaxosmithkline Research & Development Limited

Crohn's disease

Not recruiting

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Dermatitis atopic

Not recruiting

Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Alicante

What the registry says about research in the country

01 Oncology Research

Current studies focus on advanced treatments for non-small cell lung cancer, including both early-stage and metastatic cases. Investigations are ongoing in acute myeloid leukemia and lymphoma treatments.

  • Lung Cancer Therapies
  • Blood Cancer Treatments
  • Immunotherapy Approaches

Research emphasizes innovative combination therapies and targeted treatments for better patient outcomes.

02 Dermatological Studies

Comprehensive research into treatments for plaque psoriasis and atopic dermatitis, with multiple trials evaluating new therapeutic approaches for moderate to severe cases.

  • Psoriasis Management
  • Dermatitis Treatments
  • Prurigo Nodularis Research

Studies focus on developing effective solutions for chronic skin conditions.

03 Cardiovascular Research

Investigations into hypertrophic cardiomyopathy and post-heart attack treatments, including studies on specialized stent therapies and antiplatelet medications.

  • Heart Disease Management
  • Cardiomyopathy Treatment
  • Post-Infarction Care

Focus on improving outcomes for patients with various cardiac conditions.

04 Immunology and Allergies

Clinical trials examining treatments for allergic rhinoconjunctivitis and responses to various allergens, including specialized immunotherapy approaches.

  • Allergy Treatments
  • Immunotherapy Development
  • Respiratory Conditions

Research aims to improve allergy management and treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.